Dantron (chrysazin; 1,8-dihydroxyanthraquinone)
D000818:Animals; D000880:Anthraquinones / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity*; D002273:Carcinogens; D002400:Cathartics / Q000737:chemistry / Q000493:pharmacokinetics / Q000633:toxicity*; D005260:Female; D006801:Humans; D051379:Mice; D015394:Molecular Structure; D011247:Pregnancy; D051381:Rats
D000880:Anthraquinones; D002273:Carcinogens; D002400:Cathartics; C004315:danthron